Jennifer E. Sager - Concepedia

Author

Jennifer E. Sager

University of Washington

Also Known As

J E Sager, Jennifer E Sager, Jennifer E. SAGER, Jennifer E. Sager, Jennifer Sager

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Washington VIR Biotechnology (United States)Fred Hutch Cancer Center Florida International University Hospital de Clínicas de Porto Alegre

About

Jennifer E. Sager is an author at University of Washington specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	248
2	Epidemiology	4	4	95
3	Public Health	3	3	85
4	Biochemistry	3	3	138
5	Immunology	3	3	85

Jennifer E. Sager

Publications

953

Citations

H-Index

Page 1

	Year	Citations
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez, JAMA	2022	288
Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans Erica D. Smith, Tammi L. Kaeberlein, Brynn T Lydum, BMC Developmental Biology	2008	134
Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions Yoshiyuki Shirasaka, Jennifer E. Sager, Justin D. Lutz, Drug Metabolism and Disposition	2013	107
Fluoxetine- and Norfluoxetine-Mediated Complex Drug–Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4 Jennifer E. Sager, J. Lutz, R. Foti, Clinical Pharmacology & Therapeutics Complex DdisPharmacotherapyExperimental PharmacologyPharmacodynamic ModelingDrug Resistance	2014	79
Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez, Adverse EventsCovid-19 PandemicClinical EpidemiologyImmunologyClinical Trials	2021	52
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro Jennifer E. Sager, Lauren Price, Nina Isoherranen Drug Metabolism and Disposition	2016	42
In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation Jennifer E. Sager, Sasmita Tripathy, Lauren Price, Biochemical Pharmacology BiochemistryMedicineSimultaneous Reversible InhibitionVivo ExtrapolationPharmacotherapy	2016	39
Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions Weize Huang, Mariko Nakano, Jennifer E. Sager, Drug Metabolism and Disposition	2017	33
Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters David J. Wagner, Jennifer E. Sager, Haichuan Duan, Drug Metabolism and Disposition	2017	31
Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction Predictions Yongkai Sun, Paresh P. Chothe, Jennifer E. Sager, Drug Metabolism and Disposition	2017	27

Page 1